Chakravarthy, Bapsi

Combined modality management of breast cancer: development of predictive markers through proteomics. [electronic resource] - Seminars in oncology Aug 2003 - 23-36 p. digital

Publication Type: Journal Article; Review

0093-7754

10.1016/s0093-7754(03)00267-7 doi


Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Combined Modality Therapy
Female
Forecasting
Humans
Neoadjuvant Therapy
Prognosis
Prospective Studies
Proteomics
Remission Induction
Retrospective Studies
Survival Rate